Literature DB >> 17936343

Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis.

Jasenka Mazibrada1, Massimo Rittà, Michele Mondini, Marco De Andrea, Barbara Azzimonti, Cinzia Borgogna, Marco Ciotti, Augusto Orlando, Nicola Surico, Luigi Chiusa, Santo Landolfo, Marisa Gariglio.   

Abstract

OBJECTIVE: The primary aim of this study was to investigate the role of angiogenesis and inflammatory cell response in cervical carcinogenesis.
METHODS: Formalin-fixed tissue specimens from 58 uterine cervical specimens (8 CIN1, 14 CIN2, 28 CIN3, and 8 SCC), representing the different stages of cervical carcinogenesis, were immunohistochemically analyzed. Normal cervical tissue specimens were also included as controls. The present study assessed the expression of CD31 and CD105 to evaluate microvessel density (MVD), the macrophage marker CD68 and the panleukocyte marker CD45. In addition, expression of iNOS (inducible Nitric Oxide Synthase) was also evaluated.
RESULTS: MVD, measured by either CD31 or CD105, increased along the continuum from normal epithelium to squamous cell carcinoma, and a significant correlation between the CD105-MVD and the CD31-MVD was observed (r=0.8735; p<0.0001). Furthermore, the number of infiltrating macrophages was significantly associated with progression to malignancy. Interestingly, there was a close positive correlation between macrophage counts and CD105-MVD (r=0.7525; p<0.0001). In striking contrast to the other angiogenic and inflammatory markers tested, iNOS expression was significantly reduced as cervical lesion grade progressed from low to high.
CONCLUSIONS: Our findings demonstrated a positive correlation between neovascularity and macrophage counts, whereas iNOS expression displayed an inverse relationship with macrophage density and tumor progression. Low iNOS expression may modify the function of tumor-infiltrating macrophages toward a malignant phenotype that promotes tumor progression rather than an anti-tumor response.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17936343     DOI: 10.1016/j.ygyno.2007.08.095

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  38 in total

Review 1.  Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations.

Authors:  Teresa C Longoria; Krishnansu S Tewari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Multiple roles for CCR2 during fracture healing.

Authors:  Zhiqing Xing; Chuanyong Lu; Diane Hu; Yan-yiu Yu; Xiaodong Wang; Celine Colnot; Mary Nakamura; Yalei Wu; Theodore Miclau; Ralph S Marcucio
Journal:  Dis Model Mech       Date:  2010-03-30       Impact factor: 5.758

Review 3.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

4.  Interleukin-10 production by tumor infiltrating macrophages plays a role in Human Papillomavirus 16 tumor growth.

Authors:  Aline Bolpetti; João S Silva; Luisa L Villa; Ana Paula Lepique
Journal:  BMC Immunol       Date:  2010-06-07       Impact factor: 3.615

5.  Local lymphocytes and nitric oxide synthase in the uterine cervical stroma of patients with grade III cervical intraepithelial neoplasia.

Authors:  Cléber Sergioda da Silva; Marcia Antoniazi Michelin; Renata Margarida Etchebehere; Sheila Jorge Adad; Eddie Fernando Candido Murta
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

6.  Candidate biomarkers for cervical cancer treatment: Potential for clinical practice (Review).

Authors:  Miho Iida; Kouji Banno; Megumi Yanokura; Kanako Nakamura; Masataka Adachi; Yuya Nogami; Kiyoko Umene; Kenta Masuda; Iori Kisu; Takashi Iwata; Kyoko Tanaka; Daisuke Aoki
Journal:  Mol Clin Oncol       Date:  2014-06-23

7.  Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

Authors:  Mitsuhiro Nakamura; Jason M Bodily; Melanie Beglin; Satoru Kyo; Masaki Inoue; Laimonis A Laimins
Journal:  Virology       Date:  2009-03-24       Impact factor: 3.616

8.  Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Authors:  Leslie M Randall; Bradley J Monk; Kathleen M Darcy; Chunqiao Tian; Robert A Burger; Shu-Yuan Liao; William A Peters; Richard J Stock; John P Fruehauf
Journal:  Gynecol Oncol       Date:  2008-12-24       Impact factor: 5.482

9.  Endoglin mediates fibronectin/α5β1 integrin and TGF-β pathway crosstalk in endothelial cells.

Authors:  Hongyu Tian; Karthikeyan Mythreye; Christelle Golzio; Nicholas Katsanis; Gerard C Blobe
Journal:  EMBO J       Date:  2012-08-31       Impact factor: 11.598

10.  Effect of anatomy on spectroscopic detection of cervical dysplasia.

Authors:  Jelena Mirkovic; Condon Lau; Sasha McGee; Chung-Chieh Yu; Jonathan Nazemi; Luis Galindo; Victoria Feng; Teresa Darragh; Antonio de Las Morenas; Christopher Crum; Elizabeth Stier; Michael Feld; Kamran Badizadegan
Journal:  J Biomed Opt       Date:  2009 Jul-Aug       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.